Stat3/Stathmin act through PLK1 to regulate centrosome clustering.(a) Quantification of centrosome clustering in paclitaxel-treated BT-549 cells with or without Stattic (n=6 biological replicates, ≥1,200 cells per data point). (b) Positive kinase inhibitor ‘hits' identified from a screen of 400 k...
more
Stat3/Stathmin act through PLK1 to regulate centrosome clustering.(a) Quantification of centrosome clustering in paclitaxel-treated BT-549 cells with or without Stattic (n=6 biological replicates, ≥1,200 cells per data point). (b) Positive kinase inhibitor ‘hits' identified from a screen of 400 known kinase inhibitors. n=2 biological replicates, ≥400 cells per data point. Error bars (s.d.). PLK1 and aurora kinase A (AURKA) were selected as potential downstream effector candidates of Stat3–Stathmin. (c) Quantification of phosphorylated to total PLK1 and AURKA ratios in Stat3-inhibitor-treated BT-549 cells using In-Cell Western assays (n=4 biological replicates). (d) Quantification of phospho-PLK1 to PLK1 ratios in BT-549 cells stably expressing Stat3C or Stat3-Y705F and treated with Stat3 siRNA, as determined using In-Cell Western assays (n=8 biological replicates). (e) Western blot of phospho-PLK1 and PLK1 from lysates of BT-549 cells treated with Stattic or BBI-608. Tubulin is a loading control. (f) ELISA-based quantification of in vitro PLK1 activity. Quantification of PLK1 activity assay using increasing concentrations of PLK1 (left panel; n=4 biological replicates). Quantification of relative PLK1 activity using 1 mU PLK1 and increasing amounts of Stathmin (middle panel; n=4 biological replicates). Quantification of recombinant PLK1 activity in the presence of recombinant Stathmin, Stat3 and Stattic (right panel; n=4 biological replicates). 1 mU (milli unit)=1 nmole of phosphate incorporated min−1 mg−1. (g) Quantification of the effects of low and high concentrations of the PLK1 inhibitor BI-2536 and PLK1 siRNA on centrosome clustering in mitotic BT-549 cells (n=4 biological replicates, 80 cells per condition). (h) Western blot of PLK1 siRNA-treated BT-549 cells stained for PLK1 and GAPDH (loading control). (i) Immunofluorescence images of γ-tubulin (red), DNA (Hoechst, blue) and Myc-Tag (inset, green) in a mitotic BT-549 cell transiently overexpressing Myc-tagged PLK1 and treated with 1 μM Stattic (left panels). Arrows point to clustered supernumerary centrosomes. Scale bar, 5 μm. Quantification of the percentage of Myc-PLK1-expressing mitotic BT-549 cells with declustered centrosomes (right panel; n=4 biological replicates, 120 cells per condition). (j) Diagram of potential Stat3–Stathmin–PLK1 pathway. *P<0.05; **P<0.01; ***P<0.001. Error bars represent s.e.m. Statistical significance was tested between the indicated groups with analysis of variance in all graphs.
less